Pilot and Feasibility Program
试点和可行性计划
基本信息
- 批准号:10407761
- 负责人:
- 金额:$ 24.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-02-15 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AreaAwardBiomedical ResearchBostonClinicalDataDiabetes MellitusExtramural ActivitiesFacultyFosteringFundingGoalsGrantGuidelinesInstitutionInvestigationMassachusettsMentorsMetabolismMethodsNonprofit OrganizationsPaperPathogenesisPeer ReviewPublicationsResearchResearch PersonnelResearch SupportScienceTalentsTechnologyTimeTranslatingUnited States National Institutes of Healthbasedesignexperienceinnovationnovelprogramsrecruitsuccess
项目摘要
PILOT AND FEASIBILITY GRANT PROGRAM: Abstract
The Joslin Diabetes Research Center (DRC) Pilot & Feasibility Grant Program has several goals. First is to
enrich the scientific base of the DRC at Joslin and other local institutions. A second major goal is to foster
interactions between researchers at Joslin and other local institutions, and in particular to enhance interactions
between basic and clinical researchers focused on diabetes and its complications. Finally, the Program aims to
advance innovative research into the pathogenesis, treatments and potential cures for all types of diabetes and
their complications. To achieve these goals the Program sponsors an annual competition for awards to support
projects by:
1. New investigators in the diabetes field. The Pilot & Feasibility Program facilitates recruitment of talented
new investigators who typically have not yet received substantial NIH funding.
2. Experienced investigators in the diabetes field who wish to strike out in a novel direction. The Pilot &
Feasibility Program embraces promising new experimental strategies and methods.
3. Investigators from other fields embarking on a diabetes-related project for the first time. The Pilot &
Feasibility Program helps inspire established investigators to bring their expertise to the diabetes field.
The Pilot & Feasibility Program has developed a carefully designed program to attract the most competitive
applications from Joslin DRC Research Base Investigators and from investigators at neighboring institutions in
eastern and central Massachusetts. The annual competition is widely advertised and comprehensive guidelines
are distributed. Proposals are judged by internal and external reviewers chosen on the basis of expertise.
Typically, the two proposals that receive the highest scores are recommended for funding of $50,000/year for 2
years, with the second year of support contingent upon progress in the first. Although these awards are modest,
the program provides initial support to enable these investigators to develop preliminary data sufficient that will
serve as the basis for subsequent successful applications for independent extramural research support.
Over the past decade the Pilot & Feasibility Program has made 21 new awards, 18 of which were to new
investigators, which are the highest priority of this Program. Each recipient is encouraged to Joslin DRC Cores
and participates in the Enrichment program by attending the Joslin Research Retreat and presenting a Joslin
seminar in the second year. Over the past 10 years, support from the program has led to 23 publications, and
recipients leveraged Pilot & Feasibility support to obtain 13 federal grants and 12 grants from non-profit
organizations. All of the award recipients supported in the past cycle remain in diabetes research. These metrics
provide strong evidence of the success of the DRC Pilot & Feasibility Program.
飞行员和可行性赠款计划:摘要
乔斯林糖尿病研究中心(DRC)飞行员和可行性赠款计划有多个目标。首先是
在乔斯林和其他地方机构中丰富了刚果民主共和国的科学基础。第二个主要目标是养育
乔斯林和其他地方机构的研究人员之间的相互作用,尤其是为了增强相互作用
基础研究人员和临床研究人员之间的重点是糖尿病及其并发症。最后,该计划的目的是
对所有类型的糖尿病的发病机理,治疗和潜在疗法进行创新研究
他们的并发症。为了实现这些目标,该计划赞助了年度奖项,以支持
项目作者:
1。糖尿病领域的新调查人员。飞行员与可行性计划有助于招募才华
通常尚未获得大量NIH资金的新调查人员。
2。糖尿病领域的经验丰富的调查人员希望朝着一个新颖的方向罢工。飞行员&
可行性计划包含有希望的新实验策略和方法。
3。其他领域的调查人员首次开始与糖尿病相关的项目。飞行员&
可行性计划有助于激发既定的研究人员将其专业知识带入糖尿病领域。
飞行员与可行性计划已经制定了一项精心设计的计划,以吸引最具竞争力的
Joslin DRC研究基础调查人员和邻近机构的调查员的申请
马萨诸塞州东部和中部。年度竞赛是广泛宣传和全面的指南
分布。提案由内部和外部审阅者根据专业知识来判断。
通常,建议获得最高分数的两个提案,以$ 50,000/年的资金为2
多年来,第二年的支持取决于第一年的进步。尽管这些奖项是适中的,但
该计划提供了初始支持,使这些调查人员能够开发足够的初步数据
作为随后成功申请独立壁外研究支持的基础。
在过去的十年中
调查人员,这是该计划的最高优先事项。鼓励每个收件人乔斯林刚果民主共和国核心
并通过参加Joslin Research Retreat并展示Joslin来参加丰富计划
第二年的研讨会。在过去的10年中,该计划的支持已导致23个出版物,并且
接收者杠杆飞行员和可行性支持,以获得13个联邦赠款和12项非营利组织的赠款
组织。过去周期中支持的所有奖励者保留在糖尿病研究中。这些指标
提供有力的证据表明刚果民主共和国飞行员和可行性计划的成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROHIT N. KULKARNI其他文献
ROHIT N. KULKARNI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROHIT N. KULKARNI', 18)}}的其他基金
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes
探究泛素通路以了解和治疗 1 型糖尿病中细胞因子诱导的 β 细胞死亡
- 批准号:
10278303 - 财政年份:2021
- 资助金额:
$ 24.27万 - 项目类别:
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes
探究泛素通路以了解和治疗 1 型糖尿病中细胞因子诱导的 β 细胞死亡
- 批准号:
10477373 - 财政年份:2021
- 资助金额:
$ 24.27万 - 项目类别:
Enhanced pancreatic islet cell engraftment by treatment with serpin B1
丝氨酸蛋白酶抑制剂 B1 处理增强胰岛细胞植入
- 批准号:
10383270 - 财政年份:2021
- 资助金额:
$ 24.27万 - 项目类别:
Interplay between SerpinB1 and TLR2/TLR4 in beta cell regeneration
SerpinB1 和 TLR2/TLR4 在 β 细胞再生中的相互作用
- 批准号:
10094305 - 财政年份:2020
- 资助金额:
$ 24.27万 - 项目类别:
One-compound, one-islet: A high-throughput platform for small-molecule discovery
一种化合物,一种胰岛:用于小分子发现的高通量平台
- 批准号:
10450745 - 财政年份:2019
- 资助金额:
$ 24.27万 - 项目类别:
One-compound, one-islet: A high-throughput platform for small-molecule discovery
一种化合物,一种胰岛:用于小分子发现的高通量平台
- 批准号:
10356005 - 财政年份:2019
- 资助金额:
$ 24.27万 - 项目类别:
Interplay Between SERPINB1 and TLR2/TLR4 in Beta Cell Regeneration
SERPINB1 和 TLR2/TLR4 在 Beta 细胞再生中的相互作用
- 批准号:
10301008 - 财政年份:2018
- 资助金额:
$ 24.27万 - 项目类别:
Interplay Between SERPINB1 and TLR2/TLR4 in Beta Cell Regeneration
SERPINB1 和 TLR2/TLR4 在 Beta 细胞再生中的相互作用
- 批准号:
10378332 - 财政年份:2018
- 资助金额:
$ 24.27万 - 项目类别:
Regulation of Autoimmune Type 1 Diabetes by Serpins B1 and A1 (Alpha 1-Antitrypsin)
Serpins B1 和 A1(α 1-抗胰蛋白酶)对自身免疫性 1 型糖尿病的调节
- 批准号:
9556000 - 财政年份:2018
- 资助金额:
$ 24.27万 - 项目类别:
Interplay Between SERPINB1 and TLR2/TLR4 in Beta Cell Regeneration
SERPINB1 和 TLR2/TLR4 在 Beta 细胞再生中的相互作用
- 批准号:
10062405 - 财政年份:2018
- 资助金额:
$ 24.27万 - 项目类别:
相似国自然基金
生态补奖背景下草原牧户实现自主性减畜的机制、路径和政策研究
- 批准号:72374130
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
草原生态补奖政策对牧户兼业行为的影响机理研究——以内蒙古为例
- 批准号:72363025
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:72104063
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
草原生态补奖政策激励-约束下牧民生产行为决策机制及生态效应
- 批准号:
- 批准年份:2020
- 资助金额:50 万元
- 项目类别:
相似海外基金
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
- 批准号:
10709381 - 财政年份:2023
- 资助金额:
$ 24.27万 - 项目类别:
International Conference on Cancer Health Disparities
国际癌症健康差异会议
- 批准号:
10606212 - 财政年份:2023
- 资助金额:
$ 24.27万 - 项目类别:
Resource Center for Alzheimer's and Dementia Research in Asian and Pacific Americans
亚太裔美国人阿尔茨海默病和痴呆症研究资源中心
- 批准号:
10730059 - 财政年份:2023
- 资助金额:
$ 24.27万 - 项目类别:
Risk stratifying indeterminate pulmonary nodules with jointly learned features from longitudinal radiologic and clinical big data
利用纵向放射学和临床大数据共同学习的特征对不确定的肺结节进行风险分层
- 批准号:
10678264 - 财政年份:2023
- 资助金额:
$ 24.27万 - 项目类别: